Jade Biosciences, Inc.
Ownership
Ownership Structure
Who owns Jade Biosciences, Inc. (JBIO)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 81.7% of the shares are freely tradable; institutional investors hold 84.8%.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| FMR Inc | 14.35 | 9,126,877 | +28.8 | 06/30/2026 |
| Jupiter Topco LLC | 9.86 | 6,273,262 | +0.0 | 06/30/2026 |
| Fairmount Funds Management LLC | 7.16 | 4,553,494 | +0.0 | 06/30/2026 |
| RA Capital Management, LLC | 5.77 | 3,671,083 | +0.0 | 06/30/2026 |
| VR Adviser, LLC | 5.06 | 3,220,364 | +0.0 | 06/30/2026 |
| HHG PLC | 4.88 | 3,105,669 | +0.0 | 03/31/2026 |
| Bellevue Group AG | 4.81 | 3,057,996 | -12.7 | 06/30/2026 |
| Paradigm Biocapital Advisors LP | 4.49 | 2,857,405 | +0.0 | 06/30/2026 |
| BlackRock Inc | 4.41 | 2,801,451 | +21.1 | 06/30/2026 |
| Franklin Templeton Inc | 4.39 | 2,792,080 | +0.0 | 06/30/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Data as of: October 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.